Somnetics' Pioneering CPAP Device Receives the 2012 North American Frost & Sullivan Award for Product Differentiation Excellence

Somnetics' Pioneering CPAP Device Receives the 2012 North American Frost & Sullivan Award for Product Differentiation Excellence PR Newswire MOUNTAIN VIEW, California, July 18, 2012 - Transcend leverages clinically proven technology to provide an innovative CPAP option for obstructive sleep apnea MOUNTAIN VIEW, California, July 18, 2012 /PRNewswire/ -- Based on its recent analysis of the sleep disordered breathing therapeutics market, Frost & Sullivan recognizes Somnetics International, Inc.® with the 2012 North American Frost & Sullivan Award for Product Differentiation Excellence. Somnetics received this award for developing Transcend®, currently the world's smallest, lightest and most portable continuous positive airway pressure (CPAP) system. Click here for the full multimedia experience of this release - http://bit.ly/MldsEg Increasing awareness about sleep disorders and their economic impact is fueling innovation toward new levels of diagnosis, treatment and management of sleep disordered breathing to enable better long-term clinical outcomes and improving quality of life for patients. Patients also want products that are smarter, smaller, lighter, and provide greater flexibility. "Somnetics' Transcend represents the culmination of technologic innovation and cutting-edge knowledge within the sleep science community, offering a sustainable option for current and future CPAP users," said Frost & Sullivan Research Industry Analyst Gary Burk.